Evidence map›Paper›PMID 32642406›Full record

ReviewActa pharmaceutica Sinica. B2020

Delivery strategies for macromolecular drugs in cancer therapy.

Qin Guo, Chen Jiang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Micro/Nano-Motors for Enhanced Tumor Diagnosis and Therapy.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qin GuoKey Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.
Chen JiangKey Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the development of biotherapy, biomacromolecular drugs have gained tremendous attention recently, especially in drug development field due to the sophisticated functions

Indexed as

aPDL1, antibodies against PDL1Cancer therapyChiP, multifunctional chimeric peptideCHOL, cholesterolCP, Cas9-sgRNA plasmidCTCs, circulating tumor cellsCTLA4, cytotoxic T lymphocyte antigen 4DDS, drug delivery systemsDelivery strategiesDOPE, dioleoyl phosphoethanolamineDOTAP, (2,3-dioleoyloxy-propyl)-trimethylammoniumDPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholineEMT, epithelial-to-mesenchymal transitionExosomesGOx, glucose oxidaseGRVs, glucose-responsive vesiclesLFA-1, lymphocyte function antigen-1Macromolecular drugsMDP, muramyl dipeptideMembrane-camouflage systemsMFT, mifamurtideNLR, domain-like receptorsPAMAM, polyamidoaminePD1, programmed cell death protein 1PDT, photodynamic therapyPEG, polyethylene glycolPEI, polyethyleniminePGE2, prostaglandin E2PMAPs, pathogen associated molecular patternsRBC, red blood cellsrFljB, recombinant flagellinTAT, human immunodeficiency virus-1 transcription activatorTLR, toll-like receptorsTME, tumor microenvironmentTRAIL, tumor necrosis factor related apoptosis-inducing ligand

Identifiers

PMID32642406
PMCPMC7332661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.